Prostate Cancer

The addition of talazoparib to enzalutamide extended OS among men with metastatic castration-resistant prostate cancer, according to the agent’s manufacturer.

Karen E. Knudsen, MBA, PhD, embraced a straightforward but powerful principle when she assumed two key leadership positions with American Cancer Society.

People with MS had an increased risk for bladder, brain and cervical cancers compared with people without MS, according to a new study in Neurology, the medical journal of the American Academy of Neurology.

A blood test for men at the time of a metastatic prostate cancer diagnosis may predict treatment response and survival, according to study results.

Adults with Graves’ disease treated with antithyroid drugs have a higher risk for multiple types of cancer compared with the general population, according to findings published in Thyroid.

Inpatient management of people with cancer varied considerably based on their housing status, according to results of a cross-sectional study.

Photon and proton beam radiation therapies conferred similar outcomes for men with localized prostate cancer, according to results of a randomized phase 3 trial.

Chimeric antigen receptor T-cell therapy exhibited activity with minimal adverse effects for men with advanced prostate cancer, findings of a first-in-human trial showed.

When Danielle Mitchell told an acquaintance about her mission to better represent Black women in the clinical workforce, the woman responded with a personal story.

PROVIDENCE, Rhode Island — Misinformation about cancer is prevalent on social media, spanning across platforms and malignancy types, according to a presenter at the COSMO Meeting.